CLINICAL TRIALS PROFILE FOR REZUROCK
✉ Email this page to a colleague
All Clinical Trials for Rezurock
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT02841995 ↗ | A Study to Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Chronic Graft Versus Host Disease | Active, not recruiting | Kadmon Corporation, LLC | Phase 2 | 2016-08-01 | This study is being conducted to evaluate the safety, tolerability, and activity of belumosudil (formerly known as KD025) in adult subjects with chronic Graft versus Host Disease (cGVHD). |
| NCT03530995 ↗ | Drug-drug Interaction Between Belumosudil, Itraconazole, Rifampicin, Rabeprazole, and Omeprazole in Healthy Volunteers | Completed | Quotient Sciences | Phase 1 | 2018-04-28 | This is a single-center, 2-part, non-randomized, open-label study of the drug-drug interactions of belumosudil (KD025) with itraconazole, rifampicin, rabeprazole, and omeprazole in healthy male subjects. |
| NCT03530995 ↗ | Drug-drug Interaction Between Belumosudil, Itraconazole, Rifampicin, Rabeprazole, and Omeprazole in Healthy Volunteers | Completed | Kadmon Corporation, LLC | Phase 1 | 2018-04-28 | This is a single-center, 2-part, non-randomized, open-label study of the drug-drug interactions of belumosudil (KD025) with itraconazole, rifampicin, rabeprazole, and omeprazole in healthy male subjects. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Rezurock
Condition Name
Clinical Trial Locations for Rezurock
Trials by Country
Clinical Trial Progress for Rezurock
Clinical Trial Phase
Clinical Trial Sponsors for Rezurock
Sponsor Name
